Detection of the Hepatitis C Virus by RT-PCR

  • Christopher John Healey
  • Steven Read
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 16)

Abstract

The hepatitis C virus (HCV) is an orgainsm of the age of molecular biology, for its discovery and much of the research into the infection have relied heavily on molecular techniques. The development of molecular cloning enabled a successful strategy that finally identified HCV (1)as the cause of 90% of posttransfusion (2)and > 50% of sporadic non-A, non-B hepatitis (3) after the failure by immunological techniques to discover the responsible agent. It is an important infection as most infected patients developed chronic hepatitis (> 50%) that can progress to cirrhosis and hepatocellular carcinoma (4, 5, 6) . Following the identification of the viral genome, antibody tests were developed which could detect exposure to the virus (7). The presence of antibodies to HCV, however, does not distinguish between those with chronic infection and those who had cleared the virus. Chronic HCV infection can be difficult to diagnose as patients may be asymptomatic and have normal liver biochemistry (8),(9) despite abnormal liver histology. Therefore, demonstration of virus RNA (usually from serum samples) is often necessary to confirm Infection. Detection of HCV RNA requires the sensitivity of nucleic acid amplification (e.g., the polymerase chain reaction) as circulating levels of vnus RNA can be very low (10),(11). Such tests are now widely used to confirm infection, monitor the response to anti-viral therapy, and in epidemiological studies of HCV infection.

Keywords

Vortex Dioxide Magnesium Glycerol Hepatitis 

References

  1. 1.
    Choo, Q L., Kuo, G, Weiner, A. J., Overby, L R., Bradley, D. W., and Houghton, M. (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359–362.PubMedCrossRefGoogle Scholar
  2. 2.
    Aach, R., Stevens, C., Hollinger, F., Mosley, J., Peterson, D., Taylor, P., Johnson, R, Barbosa, L., and Nemo, G.(1992) Hepatitis C virus infection in post-transfusion hepatitis. N. Engl. J. Med. 325, 1325–1329.CrossRefGoogle Scholar
  3. 3.
    Alter, M. J., Margolis, H S., Krawczynski, K., Judson, F. N., Mares, A, Alexander, W. J., Hu, P. Y., Miiler, J. K, Gerber, M. A, Sampliner, R E., Meeks, E. L., and Beach, M. J.(1992) The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chrome non-A, non-B Hepatitis Study. N. Engl. J. Med. 327, 1899–1905.PubMedCrossRefGoogle Scholar
  4. 4.
    Di Bisceghe, A., Goodman, Z D., Ishak, K G., Hoofnagle, J. H., Melpolder, J. J., and Alter, H. J.(1991) Long term clinical and histological follow-up of chronic posttranfnsion hepatitis. Hepatologa 14, 969–974.CrossRefGoogle Scholar
  5. 5.
    Tong, M. J, Elfarra, N. S, Reikes, A. R, and Co, R. L(1995) Clinical outcomes after transfusion-associated hepatitis C. N. Engl J. Med. 332, 1463–1466.PubMedCrossRefGoogle Scholar
  6. 6.
    Tremolada, F., Casarin, C., Alberti, A., Drago, C., Tagger, A., Ribero, M L., Realdi, G.(1992) Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis J.Hepatol 16, 273–281.PubMedCrossRefGoogle Scholar
  7. 7.
    Kuo, G., Choo, Q. L, Alter, H. J., Gitnick, G. L., Redeker, A. G., Purcell, R. H., Miyamura, T., Dienstag, J. L., Alter, M. J., Stevens, C. E., Tegtmeier, G. E., Bonmo, F., Colombo, M., Lee, W. S., Kuo, C., Berger, K., Shuster, J. R., Overby, L. R., Bradley, D. W., and Houghton, M.(1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Sczence 244, 362–364.CrossRefGoogle Scholar
  8. 8.
    Alberti, A., Morsica, G., Chemello, L., Cavalletto, D., Noventa, F., Pontisso, P., Ruol, A. (1992) Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 340, 697,698.CrossRefGoogle Scholar
  9. 9.
    Healey, C. J., Chapman, R. W. G., and Fleming, K. A.(1995) Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases. Gut 37, 274–278.PubMedCrossRefGoogle Scholar
  10. 10.
    Hagiwara, H., Hayashi, N., Mita, E., Naito, M., Kasahara, A., Fusamoto, H., Kamada, T.(1993) Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatologv 17, 545–550.CrossRefGoogle Scholar
  11. 11.
    Lau, J. Y., Davis, G L., Kniffen, J., Qian, K. P., Urdea, M. S., Chan, C. S., Mrzokami, M., Neuwald, P. D., and Wilber, J. C.(1993) Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341, 150l–1504.CrossRefGoogle Scholar
  12. 12.
    Choo, Q. L., Richman, K. H, Han, J. H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D, Medina, S. R., Barr, P. J., Weiner, A.J., Bradley, D.W., KUO, G., and Houghton, M. (1991) Genetic organization and diversity of the hepatitis C virus. Proc Nat1 Acad. Scl USA 88, 2451–2455.CrossRefGoogle Scholar
  13. 13.
    Simmonds, P., Holmes, E. C., Cha, T.-A., Chan, S.-W., McOmish, F., Irvine, B., Beall, E., Yap, P. L, Kolberg, J., and Urdea, M. S. (1993) Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenic analysis of the NS-5 region. J Gen. Vtrol. 74, 2391–2399.CrossRefGoogle Scholar
  14. 14.
    Weiner, A. J., Brauer, M. J., Rosenblatt, J., Richman, K. H., Tung, J., Crawford, K., Bonino, F., Saracco, G, Choo, Q. L., Houghton, M, and Han, J. H.(1991) Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NSI protems and the pestivnus envelope glycoproteins. Vwology 180, 842–848.Google Scholar
  15. 15.
    Cuypers, H. T. M., Bresters, D., Winkel, I. N., Reesink, H. W., Weiner, A. J., Houghton, M., van der Peel, C. L, and Leslie, P N (1992) Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus. J. Clin. Microbial 30, 3220–3224Google Scholar
  16. 16.
    Bukh, J., Purcell, R. H., and Miller, R. H.(1992) Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl. Acad Sci. USA 89, 187–191.PubMedCrossRefGoogle Scholar
  17. 17.
    Cheung, R. C., Matsui, S M., and Greenberg, H. B(1994)Rapid and sensitive method for detection of hepatitis C virus RNA by using silica particles. J Clin Microbial 32, 2593–2597Google Scholar
  18. 18.
    Boom, R., Sol, C. J, Sahmans, M. M., Jansen, C. L., Wertheim van Dillen, P.M.E., and van der Noordaa, J (1990) Rapid and simple method for purification of nucleic acids. JClin Mcrobiol. 28, 495–503.Google Scholar
  19. 19.
    Kwok, S. and Higuchi, R.(1989) Avoiding false positives with PCR. Nature 339,237,238.CrossRefGoogle Scholar
  20. 20.
    Stuyver, L., Rossau, R., Wyseur, A., Duhamael, M., Vanderborght, B, Van Heuverswyn, H., and Maertens, G.(1993) Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay.J Gen. Virol. 74, 1093–1102PubMedCrossRefGoogle Scholar
  21. 21.
    Lai, J., Prince, A. M., Wolfe, L., and Andrus, L. (1994) A simplified method for PCR detection of hepatitis C virus RNA from human serum. PCR Methods Appl 3, 308,309.Google Scholar
  22. 22.
    McOmish, F., Yap, P. L., Dow, B. C., Follett, E. A., Seed, C., Keller, A. J., Cobam, T J., Krusius, T., Kolho, E., Naukkarinen, R., Lin, C., Lai, C., Leong, S, Medgyesr, G. A., Hejjas, M., Kiyokawa, H., Fukada, K., Cuypers, T., Saeed, A. A., Alrasheed, A. M., Lin, M., and Simmonds, P.(1994) Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J. Clm Microbiol 32, 884–892Google Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 1998

Authors and Affiliations

  • Christopher John Healey
    • 2
  • Steven Read
    • 1
  1. 1.Department of Virology, PHLSJohn Radcliffe Hospital HeadingtonOxfordUK
  2. 2.Addenbrooke’s HospitalCambridgeUK

Personalised recommendations